Skip to content

Nasdaq · CIK 0001637715

OKUR OnKure Therapeutics, Inc.

Insider trading from SEC Form 4. Last filing 19 d ago. Close $2.41 on Oct 9, 2026, +5% from the 52-week low and -54% from the high.

Last 90 days

Net insider value
-$1,157
more sold than bought
Buys
0
$0 by 0 insiders
Sells
2
$1,157 by 2 insiders
Insiders on file
12
with a Form 4 at this company

Price and insider trades, last year

OKUROct 9, 2026 · close 2.41

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at OnKure Therapeutics, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
30WeakJason A. Leverone
Chief Financial Officer
sell
$898
302 shares
-2%-
33WeakNicholas A Saccomano
President and CEO
sell
$259
87 shares
-1%-
30WeakJason A. Leverone
Chief Financial Officer
sell
$896
302 shares
-2%+62% from low-67% from high
33WeakNicholas A Saccomano
President and CEO
sell
$258
87 shares
-1%+62% from low-67% from high
30WeakJason A. Leverone
Chief Financial Officer
sell
$795
303 shares
-2%+43% from low-86% from high
33WeakNicholas A Saccomano
President and CEO
sell
$231
88 shares
-2%+43% from low-86% from high
30WeakJason A. Leverone
Chief Financial Officer
sell
$722
303 shares
-2%+32% from low-87% from high
33WeakNicholas A Saccomano
President and CEO
sell
$210
88 shares
-2%+32% from low-87% from high
50ModerateAcorn Bioventures, L.p.
owner
buy
$2.6M
1,400,000 shares
+97%+13% from low-89% from high
53ModerateCormorant Asset Management, LP
other
sell
$3.4M
1,813,439 shares
-100%+13% from low-89% from high
19WeakCormorant Asset Management, LP
owner
sell
$48k
24,300 shares
-1%+2% from low-90% from high
35WeakJason A. Leverone
Chief Financial Officer
sell
$9,178
3,122 shares
-19%0% from low-84% from high
38WeakNicholas A Saccomano
President and CEO
sell
$2,570
874 shares
-19%0% from low-84% from high

Transactions

The last 30 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Sep 21, 2026Nicholas A Saccomano
President and CEO
SOpen-market sale
Class A Common Stock
-87$2.97$25911,16019 d ago
Sep 21, 2026Jason A. Leverone
Chief Financial Officer
SOpen-market sale
Class A Common Stock
-302$2.97$89818,50019 d ago
Dec 22, 2025Jason A. Leverone
Chief Financial Officer
SOpen-market sale
Class A Common Stock
-302$2.97$89616,301Dec 23, 2025
Dec 22, 2025Nicholas A Saccomano
President and CEO
SOpen-market sale
Class A Common Stock
-87$2.97$2587,419Dec 23, 2025
Sep 30, 2025Isaac Manke
director
AGrant or award
Class A Common Stock
+5,545$0.00$015,325Oct 2, 2025
Sep 30, 2025Edward T Mathers
director
AGrant or award
Class A Common Stock
+4,125$0.00$011,399Oct 2, 2025
Sep 22, 2025Jason A. Leverone
Chief Financial Officer
SOpen-market sale
Class A Common Stock
-303$2.62$79512,603Sep 24, 2025
Sep 22, 2025Nicholas A Saccomano
President and CEO
SOpen-market sale
Class A Common Stock
-88$2.62$2313,506Sep 24, 2025
Jun 30, 2025Isaac Manke
director
AGrant or award
Class A Common Stock
+6,311$0.00$09,780Jul 2, 2025
Jun 30, 2025Edward T Mathers
director
AGrant or award
Class A Common Stock
+4,694$0.00$07,274Jul 2, 2025
Jun 23, 2025Jason A. Leverone
Chief Financial Officer
SOpen-market sale
Class A Common Stock
-303$2.38$72212,906Jun 25, 2025
Jun 23, 2025Nicholas A Saccomano
President and CEO
SOpen-market sale
Class A Common Stock
-88$2.38$2103,594Jun 25, 2025
May 28, 2025Isaac Manke
director
AGrant or award
Stock Option (right to buy)derivative
+7,650$0.00$07,650May 30, 2025
May 28, 2025Andrew John Phillips
director
AGrant or award
Stock Option (right to buy)derivative
+7,650$0.00$07,650May 30, 2025
May 28, 2025Edward T Mathers
director
AGrant or award
Stock Option (right to buy)derivative
+7,650$0.00$07,650May 30, 2025
May 28, 2025Valerie Malyvanh Jansen
director
AGrant or award
Stock Option (right to buy)derivative
+7,650$0.00$07,650May 30, 2025
May 28, 2025Michael G Grey
director
AGrant or award
Stock Option (right to buy)derivative
+7,650$0.00$07,650May 30, 2025
May 28, 2025R Michael Carruthers
director
AGrant or award
Stock Option (right to buy)derivative
+7,650$0.00$07,650May 30, 2025
May 15, 2025Acorn Bioventures, L.p.
owner
POpen-market purchase
Common Stock
+270,270$1.85$500k1,709,944May 19, 2025
May 15, 2025Cormorant Asset Management, LP
other
SOpen-market sale
Class A Common Stockindirect: See Footnote
-1,813,439$1.85$3.4M0May 19, 2025
May 15, 2025Acorn Bioventures, L.p.
owner
POpen-market purchase
Common Stockindirect: By Acorn Bioventures 2, L.P.
+1,129,730$1.85$2.1M1,129,730May 19, 2025
May 12, 2025Cormorant Asset Management, LP
owner
SOpen-market sale
Class A Common Stockindirect: See Footnotes
-24,300$1.99$48k1,813,439May 14, 2025
Apr 4, 2025Jason A. Leverone
Chief Financial Officer
SOpen-market sale
Class A Common Stock
-1,278$3.33$4,25315,053Apr 8, 2025
Apr 4, 2025Nicholas A Saccomano
President and CEO
SOpen-market sale
Class A Common Stock
-358$3.33$1,1914,198Apr 8, 2025
Apr 7, 2025Jason A. Leverone
Chief Financial Officer
SOpen-market sale
Class A Common Stock
-1,844$2.67$4,92513,209Apr 8, 2025
Apr 7, 2025Nicholas A Saccomano
President and CEO
SOpen-market sale
Class A Common Stock
-516$2.67$1,3783,682Apr 8, 2025
Mar 31, 2025Isaac Manke
director
AGrant or award
Class A Common Stock
+3,469$0.00$03,469Apr 2, 2025
Mar 31, 2025Edward T Mathers
director
AGrant or award
Class A Common Stock
+2,580$0.00$02,580Apr 2, 2025
Jan 27, 2025Samuel Agresta
Chief Medical Officer
AGrant or award
Employee Stock Option (right to buy)derivative
+45,000$0.00$045,000Jan 29, 2025
Jan 27, 2025Dylan Hartley
Chief Scientific Officer
AGrant or award
Employee Stock Option (right to buy)derivative
+45,000$0.00$045,000Jan 29, 2025

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

OKUR insider trading: OnKure Therapeutics, Inc. | InsiderTell